Published in J Autoimmun on June 01, 2003
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS One (2009) 1.16
Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes (2009) 1.08
A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases. PLoS One (2007) 1.03
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases. J Clin Cell Immunol (2016) 0.78
Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine. Stem Cells Transl Med (2015) 0.78
Association between Interleukin-10 Gene Promoter Haplotype and Schizophrenia in a Han-Chinese Study. Int J Biomed Sci (2008) 0.75
The relationship of T helper-2 pathway components interleukin-4, interleukin-10, immunoglobulin e, and eosinophils with prognostic markers in non-hodgkin lymphoma: a case-control study. Turk J Haematol (2014) 0.75
APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis. Clin Exp Med (2016) 0.75
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev (2006) 6.08
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol (2007) 4.55
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med (2002) 3.49
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity (2011) 3.38
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood (2004) 2.76
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med (2013) 2.39
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood (2010) 2.15
Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood (2011) 2.12
Tr1 cells: from discovery to their clinical application. Semin Immunol (2006) 2.05
CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev (2008) 1.85
WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med (2007) 1.77
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest (2007) 1.67
Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes (2006) 1.65
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. Int Immunol (2008) 1.58
Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood (2008) 1.58
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes (2008) 1.49
Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes (2006) 1.48
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes (2009) 1.48
Is FOXP3 a bona fide marker for human regulatory T cells? Eur J Immunol (2008) 1.47
Generation of Donor-specific T Regulatory Type 1 Cells From Patients on Dialysis for Cell Therapy After Kidney Transplantation. Transplantation (2015) 1.44
Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes (2011) 1.39
Comment on M. Guillot-Delost et al. (2008;10:834-846): Clinical-grade preparation of human natural regulatory T cells encoding the thymidine kinase suicide gene as a safety gene. J Gene Med (2009) 1.39
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest (2003) 1.32
CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev (2005) 1.27
Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells. Haematologica (2011) 1.20
Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice. Diabetes (2009) 1.18
Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes (2013) 1.17
Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol Rev (2011) 1.16
Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol (2014) 1.13
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. J Neuroimmunol (2010) 1.08
Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes (2009) 1.08
HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum Immunol (2012) 1.06
Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells. J Immunol (2005) 1.06
IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci (2004) 1.04
Understanding autoimmune diabetes: insights from mouse models. Trends Mol Med (2002) 1.04
Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. Eur J Immunol (2011) 1.03
IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J Immunol (2003) 1.03
Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trial. Transplantation (2014) 1.01
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur J Immunol (2011) 1.00
The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood (2011) 0.98
Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp (2003) 0.97
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. Mol Ther (2012) 0.93
Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica (2010) 0.93
Human tolerogenic DC-10: perspectives for clinical applications. Transplant Res (2012) 0.93
Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One (2011) 0.91
Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol (2013) 0.89
Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes. Adv Exp Med Biol (2010) 0.89
HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells. Hum Gene Ther (2011) 0.88
Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice. J Autoimmun (2002) 0.88
The role of HLA-G in immunity and hematopoiesis. Cell Mol Life Sci (2010) 0.88
Dendritic cells a double-edge sword in autoimmune responses. Front Immunol (2012) 0.87
Abnormalities of the Exocrine Pancreas in Type 1 Diabetes. Curr Diab Rep (2015) 0.87
Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice. Exp Cell Res (2006) 0.87
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J Allergy Clin Immunol (2010) 0.86
Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells. Eur J Immunol (2010) 0.85
Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe⁻/⁻ mice. Immunobiology (2011) 0.84
Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice. PLoS One (2010) 0.83
Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: implication for mouse model. Transplantation (2007) 0.83
Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice. Diabetologia (2015) 0.82
Re-establishing immune tolerance in type 1 diabetes via regulatory T cells. Novartis Found Symp (2008) 0.80
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors. Endocrinology (2002) 0.80
Autoimmune diabetic patients undergoing allogeneic islet transplantation: are we ready for a regulatory T-cell therapy? Immunol Lett (2009) 0.78
HIV-derived vectors for gene therapy targeting dendritic cells. Adv Exp Med Biol (2013) 0.78
Regulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation. Curr Opin Hematol (2005) 0.77
Correlation of Der p 2 T-cell responses with clinical characteristics of children allergic to house dust mite. Ann Allergy Asthma Immunol (2012) 0.77
Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene. Mol Ther (2012) 0.76
Standardization in flow cytometry: correct sample handling as a priority. Nat Rev Immunol (2012) 0.75
All in (IL-) 1? Transplantation (2015) 0.75
DHRS9 is a Stable Marker of Human Regulatory Macrophages. Transplantation (2017) 0.75